(Reuters Health) By Lisa Rapaport - Men treated with androgen deprivation therapy (ADT) for prostate cancer may have a higher risk of dementia than their peers who receive other treatment, a U.S. study suggests."Multiple studies now suggest that androgen deprivation therapy may be associated with c

NEW YORK (Reuters Health)By Will Boggs MD - Chromoendoscopy may improve the detection of neoplasia in patients with long-standing inflammatory bowel disease (IBD) in a non-trial clinical setting, researchers from Spain report.The "dysplasia-detection rate was superior with chromoendoscopy (CE) than

NEW YORK (Reuters Health) By Will Boggs MD- Chromoendoscopy may improve the detection of neoplasia in patients with long-standing inflammatory bowel disease (IBD) in a non-trial clinical setting, researchers from Spain report.The "dysplasia-detection rate was superior with chromoendoscopy (CE) than

NEW YORK (Reuters Health) By Joan Stephenson- Among women age 40 or older who have tested negative for human papillomavirus (HPV), increasing the screening interval for cervical cancer from 5 to 10 years does not put them at increased risk for cervical cancer or high-grade cervical neoplasia, a new

NEW YORK (Reuters Health)By Will Boggs MD - MORAL, a new risk-stratification score, accurately predicts recurrence of hepatocellular carcinoma (HCC) after liver transplcanantation, researchers report."HCC tumor biology is the most important predictor of recurrence, and it is crucial that we employ

NEW YORK (Reuters Health)By Gene Emery - Better treatment and not earlier detection with screening mammography appears to be the predominant reason why the death rate for breast cancer has declined in recent years, according to controversial results from a large U.S. database.In addition, "women we

COPENHAGEN (Reuters) By Reuters Staff - Exelixis's drug Cabometyx (cabozantinib) outperformed Pfizer's Sutent (sunitinib) in a clinical study for the treatment of metastatic kidney cancer, suggesting it has the potential to become a first-line treatment, researchers said on Monday.The drug i

NEW YORK (Reuters Health) By Will Boggs MD - Postmastectomy radiotherapy (PMRT) reduces the risk of recurrent breast cancer for women with positive lymph nodes, but the decision to undergo PMRT requires clinical judgment and full involvement of the patient, according to an updated guideline."Radiat

NEW YORK (Reuters Health) By David Douglas - In patients with esophageal cancer, increasing the interval between neoadjuvant chemoradiotherapy and resection beyond six weeks is associated with better odds of pathologic complete response, according to a new study."Our findings suggest that there are

(Reuters Health) By Lisa Rapaport - Variations in a gene involved in circadian rhythms that control everything from cell division to sleep may also promote the spread of breast cancer to other organs, a new study suggests.In mouse studies, researchers showed how having slightly different versions of

NEW YORK (Reuters Health) By Will Boggs MD - A modified staging classification for pancreatic neuroendocrine tumors (pNETs) that incorporates elements from the American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) provides better risk stratification than exi

(Reuters Health) By Lisa Rapaport - Having a vasectomy doesn't increase a man's risk of developing prostate cancer or dying from it, a U.S. study suggests.Previous research has been mixed about the risk of prostate cancer associated with vasectomy."Our study provides some reassurance that h

NEW YORK (Reuters Health) By Gene Emery - Whether it's radiation, surgery or just watchful waiting, the three key strategies for dealing with prostate cancer discovered by PSA screening seem to be equally effective, according to a British study that followed 1,643 men over a median of 10 years.D